Here is the "oversold" message from Gaining Green - suggests 30% upside
Prana Biotechnology Limited (NASDAQ:PRAN) was downgraded by MLV & Co. from a “buy” rating to a “hold” rating in a research note issued on Monday, Analyst Ratings Network reports. They currently have a $3.00 price target on the stock, down from their previous price target of $11.00. MLV & Co.‘s price target suggests a potential upside of 30.43% from the company’s current price. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares fell -4.13% in last trading session and ended the day on $2.32. PRAN return on equity ratio is recorded as -143.60% and its return on assets is -113.60%. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) yearly performance is 3.11%.